We are live on ! Find out more
OMGA

Omega Therapeutics, Inc. Common Stock
OMGA

Delisted

OMGA was delisted on the 24th of February, 2025.

Back to rankings

63 hedge funds and large institutions have $152M invested in Omega Therapeutics, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 15 increasing their positions, 19 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 10

38% more capital invested

Capital invested by funds: $109M → $152M (+$42.1M)

9% more funds holding

Funds holding: 58 → 63 (+5)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

21% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 19

49% less call options, than puts

Call options by funds: $61K | Put options by funds: $119K

Holders
63
Holders Change
+5
Holders Change %
+8.62%
% of All Funds
0.92%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
16
Increased
15
Reduced
19
Closed
10
Calls
$61K
Puts
$119K
Net Calls
-$58K
Net Calls Change
-$117K

Top Buyers

Rank Fund Capital Flow
1
BOCH
Blue Owl Capital Holdings
New York
+$2.14M
2
Citigroup
Citigroup
New York
+$969K
3
ZIM
Zacks Investment Management
Illinois
+$621K
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$605K
5
Morgan Stanley
Morgan Stanley
New York
+$200K

Top Sellers

Rank Fund Capital Flow
1
AG
Artal Group
Luxembourg
-$2.45M
2
6CM
683 Capital Management
New York
-$797K
3
Millennium Management
Millennium Management
New York
-$376K
4
KCM
Knoll Capital Management
Florida
-$372K
5
BlackRock
BlackRock
New York
-$299K
Name Holding Trade Value Shares
Change 		Change in
Stake
FP
1
Flagship Pioneering
Massachusetts
$88M – – –
Fidelity Investments
2
Fidelity Investments
Massachusetts
$15.9M +$187K +92,473 +2%
HP
3
Harbourvest Partners
Massachusetts
$10.6M – – –
State of Wisconsin Investment Board
4
State of Wisconsin Investment Board
Wisconsin
$5.59M – – –
Vanguard Group
5
Vanguard Group
Pennsylvania
$4.54M +$47.7K +23,553 +2%
BlackRock
6
BlackRock
New York
$4.16M -$299K -147,659 -10%
AG
7
Artal Group
Luxembourg
$3.98M -$2.45M -1,209,515 -48%
BOCH
8
Blue Owl Capital Holdings
New York
$3.18M +$2.14M +1,055,882 New
PIM
9
Platinum Investment Management
Australia
$2.67M -$476 -235 -0%
Citigroup
10
Citigroup
New York
$1.44M +$969K +478,005 +68,482%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$1.44M +$38.6K +19,056 +4%
State Street
12
State Street
Massachusetts
$1.36M +$33K +16,300 +4%
7IH
13
72 Investment Holdings
Connecticut
$1.06M – – –
SOMRS
14
State of Michigan Retirement System
Michigan
$945K – – –
ZIM
15
Zacks Investment Management
Illinois
$922K +$621K +306,426 New
Jacobs Levy Equity Management
16
Jacobs Levy Equity Management
New Jersey
$898K +$605K +298,281 New
Northern Trust
17
Northern Trust
Illinois
$594K -$7.78K -3,840 -2%
Morgan Stanley
18
Morgan Stanley
New York
$547K +$200K +98,432 +118%
Squarepoint
19
Squarepoint
New York
$417K +$142K +69,880 +102%
Bank of New York Mellon
20
Bank of New York Mellon
New York
$393K +$117K +57,832 +80%
Point72 Asset Management
21
Point72 Asset Management
Connecticut
$389K – – –
6CM
22
683 Capital Management
New York
$346K -$797K -393,242 -77%
Susquehanna International Group
23
Susquehanna International Group
Pennsylvania
$200K +$543 +268 +0.4%
RC
24
RBF Capital
California
$199K -$7.59K -3,743 -5%
Charles Schwab
25
Charles Schwab
California
$196K – – –
1
2 3

OMGA Hedge Fund Activity: Q4 2023 in Review

63 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Omega Therapeutics, Inc. Common Stock (OMGA) for Q4 2023, worth a combined $152M — up 38% from $109M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new OMGA positions and 10 closed out — a net gain of 6 holders — while 15 added to existing stakes and 19 trimmed.

The largest buyer was Blue Owl Capital Holdings, opening a new position worth an estimated $2.14M. The largest seller was Artal Group, cutting an estimated $2.45M.

  • 63 institutional investors held Omega Therapeutics, Inc. Common Stock (OMGA) as of Q4 2023, up from 58 in Q3 2023.
  • Funds reported $152M of Omega Therapeutics, Inc. Common Stock stock for Q4 2023, up 38% quarter-over-quarter.
  • 16 funds opened new Omega Therapeutics, Inc. Common Stock positions in Q4 2023 and 10 closed out, a net change of +6 holders.
  • The largest Omega Therapeutics, Inc. Common Stock buyer in Q4 2023 was Blue Owl Capital Holdings, an estimated $2.14M added.
  • The largest Omega Therapeutics, Inc. Common Stock seller in Q4 2023 was Artal Group, an estimated $2.45M sold.

Based on aggregated 13F filings for Q4 2023.